
Sisram Medical Ltd
HKEX:1696

Sisram Medical Ltd
Revenue
Sisram Medical Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Sisram Medical Ltd
HKEX:1696
|
Revenue
$349.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
![]() |
Nano-X Imaging Ltd
NASDAQ:NNOX
|
Revenue
$11.3m
|
CAGR 3-Years
106%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Revenue
$41m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
28%
|
|
![]() |
Inmode Ltd
NASDAQ:INMD
|
Revenue
$394.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Revenue
$59.7m
|
CAGR 3-Years
40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
Epitomee Medical Ltd
TASE:EPIT
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Sisram Medical Ltd
Glance View
Sisram Medical Ltd. is an investment holding company. The firm has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The firm's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The firm sells its products in domestic and foreign markets.

See Also
What is Sisram Medical Ltd's Revenue?
Revenue
349.1m
USD
Based on the financial report for Dec 31, 2024, Sisram Medical Ltd's Revenue amounts to 349.1m USD.
What is Sisram Medical Ltd's Revenue growth rate?
Revenue CAGR 5Y
15%
Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Sisram Medical Ltd have been 6% over the past three years , 15% over the past five years .